In March 2023, Japan’s Ministry of Health and Labor Welfare approved Novo Nordisk’s once-weekly subcutaneous glucagon-like peptide-1
Unfortunate to see PM’s ‘Make in India’ dream being bulldozed
Take proper precautions and seek timely treatment!
The company has reported total income of Rs. 6738.4 crores during the period ended June 30, 2023
Astec LifeSciences has reported total income of Rs. 144.55 crores during the period ended June 30, 2023
The company has reported total income of Rs. 1185.39 crores during the period ended June 30, 2023
Dr. Lal Path Labs Ltd. has reported total income of Rs. 555.4 crores during the period ended June 30, 2023
The company has reported total income of Rs. 1052.79 crores during the period ended June 30, 2023
Cipla has reported total income of Rs. 6465.18 crores during the period ended June 30, 2023
The approved product has an estimated market size of around US$ 210 million for the twelve months ending May 2023
Subscribe To Our Newsletter & Stay Updated
